AI最尴尬的短板，中国科学院出手了

TL;DR - The Chinese Academy of Sciences’ Zhijing team unveiled an engineering stack for social intelligence in AI: the SoMBench benchmark, Zing models and training system, and Actio deployment architecture. It aims to make social reasoning measurable, trainable, and reliable in real-world interactions.

• SoMBench covers 71 tasks across belief inference, emotion understanding, social norms, and relationship modeling; the best of 20 tested models scored 72.08%.
• Zing uses weakness-targeted synthetic data, two-stage fine-tuning and reinforcement learning, plus on-policy distillation to reduce forgetting.
• Reported five-benchmark averages were 79.80 for multimodal Zing-27B and 76.32 for text-only Zing-32B, narrowly exceeding the cited GPT-5.5 and DeepSeek-V4-Pro results.
• Actio dynamically routes social skills, explicit belief-state memory, reusable reasoning experience, and culturally grounded retrieval during inference.

TL;DR - Feishu Shennuo launched Marvy 2.0, a multi-agent system that coordinates the full overseas marketing workflow. It aims to make AI-driven decisions more trustworthy through traceable execution, human approval, and learning from campaign outcomes.

• AgentOS coordinates five agents for market research, media strategy, creative production, ad placement, and data analysis under a Supervisor Agent.
• Marvy combines general-purpose models with marketing data, specialized skills, linear programming, and reinforcement learning for tasks such as budget allocation.
• A Trace→Eval→Agent loop records workflows, evaluates execution and outcomes, and feeds lessons into future campaigns.
• Company-reported results include 74% higher optimization efficiency and 89% less human time in one Nigerian campaign; these claims were not independently verified in the article.

TL;DR - This technology-news roundup highlights China’s growing AI and robotics position, including praise from Nvidia and Tesla leaders, Kimi K3’s launch, and Unitree G1’s engineering maturity.

• Jensen Huang said models such as DeepSeek and Kimi benefit the industry; Elon Musk predicted China could eventually lead AI.
• Kimi K3 reportedly has 2.8 trillion parameters and a 1-million-token context window, targeting long-horizon coding and knowledge work.
• Japanese engineers concluded after dismantling Unitree’s G1 humanoid that closing the technology gap quickly would be difficult.
• OpenAI and Anthropic reportedly sought tighter restrictions on open-weight models, while Microsoft, Nvidia, Meta, IBM, and others publicly backed open AI.

TL;DR - 即梦AI联合抖音电商和艾菲奖发起AI广告创作大赛，鼓励用户用生成式视频工具改编经典品牌内容。该活动展示了AI视频在广告创意与品牌营销中的实际应用。

• 即梦App提供分身演绎、一键跟拍等功能，可生成12秒以内的短视频。
• Web端支持剧情反转、视觉特效和完整故事设定，面向12秒以上的视频创作。
• 大赛获得多个知名品牌授权，设置品牌、公益等五个创作方向。
• 作品将按创新能力、技术水平、故事设定及视听表达等维度评选。

TL;DR - Insilico Medicine nominated ISM9528, an AI-discovered, brain-penetrant, non-opioid oral pain drug, as a preclinical candidate. It targets a previously unlinked pain mechanism and showed promising efficacy, safety, and pharmacokinetics in animal studies.

• PandaOmics identified and prioritized the undisclosed “Target Z” using omics, literature, and multimodal data; knockout studies supported its role in pain.
• Chemistry42 generated and optimized ISM9528 for potency, selectivity, brain penetration, metabolic stability, and bioavailability.
• In rodent pain models, ISM9528 matched or outperformed pregabalin and showed longer-lasting analgesia than morphine in one intravenous study.
• The company reports wide safety margins in 28-day rat and dog studies and plans GLP toxicology in October 2026, followed by clinical trials in 2027.

TL;DR - Qualcomm and IDC outlined a “personal AI” vision in which agents run across phones, PCs, glasses, and wearables using coordinated on-device, edge, and cloud computing. The shift could make AI more personalized and proactive while reshaping device architectures and ecosystems.

• Personal AI depends on persistent sensing, personal memory, privacy safeguards, natural interaction, and cross-device continuity.
• Agent workloads combine perception, memory, reasoning, and tool execution, requiring high-performance, low-power heterogeneous computing.
• Qualcomm highlighted its Oryon CPU, Adreno GPU, Hexagon NPU, sensor hub, memory, and unified software stack as an implementation foundation.
• IDC expects phones to serve as the central personal-AI hub, with glasses and other devices acting as additional contextual interfaces.

TL;DR - Byterna Therapeutics raised tens of millions of yuan in Pre-A funding to advance AI-designed circular mRNA therapies, including an in vivo CAR-T candidate and personalized cancer vaccines.

• Funds will support a clinical filing for a dual-target circular mRNA in vivo CAR-T therapy currently in an investigator-initiated trial.
• Byterna applies AI to neoantigen prediction and sequence design for personalized circular mRNA cancer vaccines.
• The company and investor Insilico Medicine plan to build an AI-native R&D engine spanning circular mRNA design through clinical translation.
• The platform combines AI design, circular mRNA, and targeted lipid nanoparticle delivery.

TL;DR - Sinopharm and Harbour BioMed formed a joint innovation consortium to develop drugs, combining AI-enabled antibody discovery with clinical development, manufacturing, and commercialization capabilities.

• The collaboration targets oncology and immuno-inflammatory diseases across the drug-development lifecycle.
• Harbour BioMed will contribute its Harbour Mice fully human antibody platform and AI-based antibody discovery capabilities.
• Sinopharm will support clinical trials, commercial-scale process development, clinical-sample manufacturing, and sales.
• Both companies will share R&D costs and product rights according to agreed proportions.